Luckily, I’m not making public policy and I’m not an elected politician or part of the administration when it comes to, you know, corporations or school districts, but I think that we’ve seen certainly in the course of this pandemic that vaccine mandates are effective. Jen Ashton: Well first of all, you know I like to stay in my Lane, and my lane is one of being a doctor and that of science. Gretchen: Vaccine mandates, obviously a big hot topic right now we’re seeing with government workers, then California became the first state for schools so should we be vaccinating children and should be required for them to attend school. Should we be vaccinating children? And should it be required for them to attend school?ĭr. If you talk to infectious disease experts, they say right now, it’s all about Delta, but tomorrow it may be another very and so that’s why we can’t relax and we can’t take our eye off the ball when you talk about what we’re dealing with with this pandemic and dealing with this virus. So that’s why there’s a push to vaccinate so many people, not just here in this country, but around the world. As the saying goes, viruses mutate for a living, so as long as there is a part of the world where this virus can circulate and replicate there will be new variants whether those variants are more dangerous to human beings or not remains to be seen, but that is always a possibility. I think the short answer is yes, we should all be concerned about the emergence of new variants. Should we be concerned about more variants in the future maybe the near future as we grow closer to the the holiday season or do you believe the Delta variant is what we will now call COVID-19?ĭr. Ashton, it seems to now be the dominant strain, at least in our area, in the Midwest of the country. Jake: And we’ve talked about the Delta variant, so much Dr. This is about a situation where medically I think the evidence is pretty clear you want to do more and not less. So, I think that the more we have in our tool box, the better we will be, but whether it’s the Regeneron antibody cocktail or this Merck antiviral pill, they are not substitutes for vaccination. Jen Ashton: I think when you talk about this anti-viral pill, for example, that’s being developed by Merck, they are asking for emergency use authorization, it’s possible, I want to underscore possible, that we can see that by the end of this calendar year and people should think of that similarly to the medication Tamiflu as both prevention and for treatment for influenza. Gretchen: What are your thoughts about the Merck pill to treat COVID?ĭr. They also took a look at what the upcoming flu season could hold with COVID in the mix. Jen Ashton over a wide array of questions in regards to the pandemic such as the Merck COVID pill, and what impact it could have on treatment. The Daybreak team spoke with ABC’s chief medical correspondent Dr.
0 kommentar(er)
